Childhood Retinoblastoma Program

About the Childhood Retinoblastoma Program

Retinoblastoma is an eye tumor that affects young children, typically before 5 years of age. With an accurate diagnosis, more than 95 percent of children will successfully recover from the disease.

The Retinoblastoma Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center offers the latest in diagnosis and treatment options, as well as access to a wide range of pediatric subspecialists to help children diagnosed with retinoblastoma manage the rigors of treatment, and effectively transition back into their lives.

How We Diagnose and Treat Childhood Retinoblastoma

Our doctors will start with a comprehensive eye exam while your child is under anesthesia. We take this approach to ensure that the doctor can carefully examine the complete eye.

After the examination, your child's doctor will order several advanced imaging scans to investigate the eye further. They may also recommend that you meet with genetic counselors to discuss taking a blood sample that looks for the abnormal retinoblastoma gene.

After testing is complete, the doctor will determine the number, size, location, and spread of the tumor(s) and develop a treatment plan. Most children respond well to treatment and retain sight in the affected eye.

Treatments may include:

  • Chemotherapy: We are typically able to treat retinoblastoma with a promising new form of chemotherapy known as intra-arterial chemotherapy. The specialist will inject chemotherapy directly into one of the eye's main blood vessels rather than into the body. This approach requires fewer treatments and causes fewer side effects. We also use systemic chemotherapy and intravitreal chemotherapy.
  • Surgery: If the tumor does not respond to other treatments, we may need to perform surgery on the eye.
  • Focal therapy: We use cryotherapy (cold) and thermotherapy (heat) to treat small tumors.
  • Radiation therapy: Doctors may use external radiation or targeted radiation with plaque brachytherapy.
  • Stem cell transplant: For the rare patient with metastatic disease, high-dose chemotherapy with stem cell transplant is an option that we can provide.

Once the treatment is complete, we will connect you with our pediatric survivorship programs. Through these programs, we will continue to monitor your child's health and well-being.

Childhood Cancer Clinical Trials

Find answers to common questions about clinical trials for childhood cancer, including whether or not a clinical trial may be the right choice for your child. Contact us and we can help you navigate your options.

Clinical Trials for Pediatric Patients

Childhood Retinoblastoma Clinical Trials and Research

Children with retinoblastoma may have access to innovative clinical trials that improve the care and treatment of the disease. Talk to your child's care team to understand if your child is eligible to participate.

Our Childhood Retinoblastoma Program Specialists

At Dana-Farber/Boston Children's, your child will have access to leading pediatric cancer doctors who specialize in eye tumors, such as retinoblastoma.

At the core of your child's treatment team is a pediatric oncologist specializing in treating children with retinoblastoma. Many of our physicians are also active researchers, so our patients can access the very best and up-to-date treatments available.

From there, we build the best team to carry out your child's treatment plan.

The team may include:

  • Pediatric ophthalmologists
  • Surgical oncologists
  • Pediatric oncology nurses
  • Radiation oncologists
  • Interventional radiologists

We round out the team with experts who help the child prepare for life during and after treatment, including psychologists, child life specialists, social workers, nutritionists, and school specialists. See our entire Childhood Solid Tumor Treatment Team.